Market Place
Sourcing Support
All News #Library
Biotech
Spyglass Pharma Reports Successful 12-Month Phase 1/2 Trial
09 Mar 2026 //
GLOBENEWSWIRE
Spyglass Pharma Completes Ipo With Full Underwriters` Share
09 Feb 2026 //
GLOBENEWSWIRE
Agomab, Spyglass Head To Nasdaq With Ipos Totaling $350M
06 Feb 2026 //
FIERCE BIOTECH
Spyglass Pharma Initiates Phase III Trials For BIM-IOL System
20 Jan 2026 //
GLOBENEWSWIRE
Immunology Biotech Agomab, Eye-Focused Spyglass Share IPO Plans
19 Jan 2026 //
FIERCE BIOTECH
Spyglass Pharma Reports Positive 36-Month Human Trial Results
10 Nov 2025 //
GLOBENEWSWIRE
SpyGlass Pharma Raises $75M for Glaucoma Drug Delivery Platform
02 Jun 2025 //
GLOBENEWSWIRE
SpyGlass Pharma Shows 18-Month Data on IOL Drug Delivery Platform
24 Apr 2025 //
GLOBENEWSWIRE
SpyGlass Pharma Names Chetan Pujara Chief R&D Officer
27 Mar 2025 //
GLOBENEWSWIRE
SpyGlass Completes Enrollment in Glaucoma Drug Delivery Study
19 Nov 2024 //
GLOBENEWSWIRE
SpyGlass Pharma Presents 18-Month Data On Drug Delivery Platform
17 Oct 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.